1. Home
  2. TECX vs AVXL Comparison

TECX vs AVXL Comparison

Compare TECX & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$32.90

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.66

Market Cap

430.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
AVXL
Founded
2019
2004
Country
United States
United States
Employees
51
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
430.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TECX
AVXL
Price
$32.90
$4.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$80.40
$22.00
AVG Volume (30 Days)
380.4K
875.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$2.86
52 Week High
$35.99
$13.99

Technical Indicators

Market Signals
Indicator
TECX
AVXL
Relative Strength Index (RSI) 67.84 56.01
Support Level $16.83 $3.60
Resistance Level $35.99 $4.88
Average True Range (ATR) 2.81 0.28
MACD 0.91 0.02
Stochastic Oscillator 80.72 49.21

Price Performance

Historical Comparison
TECX
AVXL

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: